EntoZyme
PrivateLast Round
Seed
Oct 26, 2023
Total Funding Raised
$320,000
Company Overview
EntoZyme operates in Energy & Sustainability and is based in Sydney. Its latest recorded funding round was a Seed round in October 2023.
EntoZyme is a biotechnology company that develops genetic engineering techniques to process various organic waste streams and produce valuable enzymes and bioactive compounds.
Sector
Energy & Sustainability
Verticals
Biotechnology, Circular Economy, Waste Management, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EntoZyme Comparables
Compare EntoZyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ByBug | 85% | |
| BugEra | 80% | |
| Schwarz Group | 78% |
For institutional investors. Book with your work email.
EntoZyme Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EntoZyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Macquarie University Incubator | Seed |
| UNSW Founders | Seed |
| Main Sequence Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 145% MoM.
- Oct 26, 2023
$320K round led by Main Sequence Ventures.
For institutional investors. Book with your work email.
EntoZyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EntoZyme's valuation, stock price, and market status.
Is EntoZyme a public or private company?
EntoZyme is a private company.
What is the current stock price of EntoZyme?
EntoZyme is a private company, so its shares have no public market price. Caplight tracks EntoZyme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EntoZyme worth (valuation)?
Valuation information for EntoZyme is not publicly available.
Can I buy EntoZyme stock?
EntoZyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EntoZyme's last funding round?
EntoZyme's most recent funding round was Seed on October 26, 2023.
Who are the main investors in EntoZyme?
Key investors in EntoZyme include Main Sequence Ventures.
Will EntoZyme IPO soon?
No public IPO plans have been announced for EntoZyme.
How can I track EntoZyme secondary market activity?
Caplight tracks bids, offers, and trades in EntoZyme's shares on secondary markets.